Efficacy of Bortezomib in Systemic AL Amyloidosis With Relapsed/Refractory Clonal Disease

Haematologica - Italy
doi 10.3324/haematol.11627
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Safety and Efficacy of an Oncolytic Viral Strategy Using Bortezomib With ICE/R in Relapsed/Refractory HIV-positive Lymphomas

Blood advances
Hematology
2018English

Retreatment With Bendamustine-Bortezomib-Dexamethasone in a Patient With Relapsed/Refractory Multiple Myeloma

Case Reports in Hematology
2016English

Daratumumab, Bortezomib and Dexamethasone (Dvd) vs Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (Rrmm): Efficacy and Safety Update (Castor)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Efficacy of Single-Agent Bortezomib vs. Single-Agent Thalidomide in Patients With Relapsed or Refractory Multiple Myeloma: A Systematic Comparison

European Journal of Haematology
MedicineHematology
2007English

Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2017English

Phase 2 Trial of Ixazomib in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib

Blood Cancer Journal
OncologyHematology
2015English

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Immunogenetic Characterization of Clonal Plasma Cells in Systemic Light-Chain Amyloidosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2020English

Treatment Patterns and Outcome Following Initial Relapse or Refractory Disease in Patients With Systemic Light Chain Amyloidosis

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy